US authorises Pfizer COVID-19 pill, first for at-home use
23 Dec 2021
Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalisations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial.